Omeros Corporation

NasdaqGM:OMER Stock Report

Market Cap: US$597.5m

Omeros Dividends and Buybacks

Dividend criteria checks 0/6

Omeros does not have a record of paying a dividend.

Key information

n/a

Dividend yield

2.8%

Buyback Yield

Total Shareholder Yield2.8%
Future Dividend Yield0%
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

Recent updates

Omeros Q3 2024 - Updates On OMIDRIA And Narsoplimab Lead To Liquidity Concerns

Nov 17

Omeros: Troubled Company Working Its Way Out Of The Morass

Jul 19

Omeros: Still Worth A Look Despite Narsoplimab Woes

Feb 14

Is Omeros (NASDAQ:OMER) A Risky Investment?

Jul 26
Is Omeros (NASDAQ:OMER) A Risky Investment?

Omeros (NASDAQ:OMER) Is Making Moderate Use Of Debt

Mar 17
Omeros (NASDAQ:OMER) Is Making Moderate Use Of Debt

Omeros: Taking It To The Max

Oct 05

Omeros falls 11% after reporting clinical data for COVID-19 therapy

Sep 15

Omeros: Managing An Investment After A Winning Trade

Aug 16

Omeros granted FDA’s Orphan Drug designation for PNH candidate

Jul 28

Omeros: Follow The Bouncing Ball

Jul 04

Omeros: On Death's Door

Jun 02

Omeros: The Weight Of The Wait, A Conundrum

May 03

Omeros: Despite Its Promise, The CRL Is A Huge Obstacle

Feb 21

Omeros: A New Year Beckons

Dec 06

Some Analysts Just Cut Their Omeros Corporation (NASDAQ:OMER) Estimates

Dec 04
Some Analysts Just Cut Their Omeros Corporation (NASDAQ:OMER) Estimates

Omeros: What's Left

Oct 15

Omeros: The Prize Is Nigh (Again)

Sep 14

Omeros: PDUFA Delay Presents An Opportunity

Jul 03

Omeros posts preliminary results from early-stage OMS906 trial

Jun 09

Should Shareholders Reconsider Omeros Corporation's (NASDAQ:OMER) CEO Compensation Package?

Jun 05
Should Shareholders Reconsider Omeros Corporation's (NASDAQ:OMER) CEO Compensation Package?

Omeros posts preliminary results from COVID-19 patients treated with narsoplimab

May 28

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if OMER's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if OMER's dividend payments have been increasing.

Dividend Yield vs Market

Omeros Dividend Yield vs Market
How does OMER dividend yield compare to the market?
SegmentDividend Yield
Company (OMER)n/a
Market Bottom 25% (US)1.4%
Market Top 25% (US)4.5%
Industry Average (Pharmaceuticals)2.5%
Analyst forecast (OMER) (up to 3 years)0%

Notable Dividend: Unable to evaluate OMER's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate OMER's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate OMER's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as OMER has not reported any payouts.

Discover strong dividend paying companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:34
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Omeros Corporation is covered by 20 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gregory HarrisonBofA Global Research
Jason KolbertB. Riley Wealth
Ritu BaralCanaccord Genuity